Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Regenxbio Inc’s stock clocked out at $6.72, down -3.03% from its previous closing price of $6.93. In other words, the price has decreased by -$3.03 from its previous closing price. On the day, 1.1 million shares were traded.
Ratios:
To gain a deeper understanding of RGNX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 3.05. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.37.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on February 11, 2025, Downgraded its rating to Neutral and sets its target price to $14 from $38 previously.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 30 ’24 when VITTAL VASISTA bought 20,041 shares for $7.41 per share.
KARABELAS ARGERIS N sold 10,000 shares of RGNX for $101,052 on Oct 01 ’24. The Director now owns 11,286 shares after completing the transaction at $10.11 per share. On Sep 03 ’24, another insider, KARABELAS ARGERIS N, who serves as the Director of the company, sold 10,000 shares for $11.56 each. As a result, the insider received 115,588 and left with 11,286 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.95 while its Price-to-Book (P/B) ratio in mrq is 1.10.
Stock Price History:
Over the past 52 weeks, RGNX has reached a high of $28.80, while it has fallen to a 52-week low of $6.56. The 50-Day Moving Average of the stock is -13.12%, while the 200-Day Moving Average is calculated to be -37.88%.
Shares Statistics:
A total of 49.53M shares are outstanding, with a floating share count of 44.72M. Insiders hold about 9.75% of the company’s shares, while institutions hold 87.33% stake in the company.
